Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57–66.
2. Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, et al. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell. 2000;11(5):1919–32.
3. Harshyenee KK, Ajmera P, Agarwal A, Dahiya A, Parripati VK. Maple syrup urine disease: an uncommon cause of neonatal febrile seizures. Cureus. 2023;15(6): e40826.
4. Liu Q, Li F, Zhou J, Liu X, Peng J, Gong L. Neonatal maple syrup urine disease case report and literature review. Medicine (Baltimore). 2022;101(50): e32174.
5. Patil R, Giridhar S, Umadevi L, Rathinasamy M, Antony J. Maple syrup urine disease presenting as severe neonatal metabolic encephalopathy: a case report. Int J Contemp Pediatr. 2020;7:2072–6.